Article

Scheimpflug device, ultrasound pachymetry both repeatable for CCT measurements

San Francisco-Both ultrasound pachymetry and a proprietary Scheimpflug imaging device (Galilei Dual Scheimpflug Analyzer, Ziemer Ophthalmic Systems) produced excellent repeatability of central corneal thickness (CCT) measurements, and the repeatability was strong for both "virgin" and post-refractive eyes, according to Mitchell P. Weikert, MD, MS, assistant professor of ophthalmology, Baylor College of Medicine, Houston.

San Francisco-Both ultrasound pachymetry and a proprietary Scheimpflug imaging device (Galilei Dual Scheimpflug Analyzer, Ziemer Ophthalmic Systems) produced excellent repeatability of central corneal thickness (CCT) measurements, and the repeatability was strong for both “virgin” and post-refractive eyes, according to Mitchell P. Weikert, MD, MS, assistant professor of ophthalmology, Baylor College of Medicine, Houston.

He presented data from a study of 77 eyes in 39 patients who were candidates for refractive surgery, and 39 eyes in 21 post-refractive surgery patients.

“Ultrasound pachymetry is considered the gold standard for CCT measurements, but it’s not without its problems,” Dr. Weikert said. “It requires the operator to place the probe directly in the center of the cornea, and there are other issues such as tissue compression. Scheimpflug imaging, on the other hand, is non-contact, repeatable, and can provide a measurement of a larger area of the cornea, not just the center.”

In this study, a single examiner made three consecutive measurements with each device in patients who had virgin corneas, postLASIK patients at least 3 months after surgery, and postPRK patients at least 6 months after surgery.

They found no statistically significant difference in the CCT measurements of virgin eyes taken with either instrument. In the post-refractive surgery patients, the mean corneal thickness as measured by the Scheimpflug device was 500.4 µm (± 44.8 µm), and it was 494.3 µm (± 50.3 µm) as measured by ultrasound pachymetry. The difference was small (–6.2 µm ± 9.9 µm) but statistically significant (p = 0.0004).

Dr. Weikert said both devices have high repeatability of measurements when used carefully by a single examiner. He added that the dual Scheimpflug instrument tended to measure thicker corneas in general.

Although he now uses it as the primary method for checking CCT before refractive surgery, other practitioners who choose to do so may wish to re-check thinner corneas with ultrasound pachymetry, Dr. Weikert concluded.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
© 2025 MJH Life Sciences

All rights reserved.